Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes

Mary E. Lacy, Paola Gilsanz, Andrew J. Karter, Charles P. Quesenberry, Mark J. Pletcher, Rachel Whitmer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

OBJECTIVE: Individuals with type 1 diabetes have experienced an increase in life expectancy, yet it is unknown what level of glycemic control is ideal for maintaining late-life brain health. We investigated the association of long-term glycemic control with dementia in older individuals with type 1 diabetes.

RESEARCH DESIGN AND METHODS: We followed 3,433 members of a health care system with type 1 diabetes, aged ≥50 years, from 1996 to 2015. Repeated measurements of hemoglobin A1c (HbA1c), dementia diagnoses, and comorbidities were ascertained from health records. Cox proportional hazards models were fit to evaluate the association of time-varying glycemic exposure with dementia, with adjustment for age, sex, race/ethnicity, baseline health conditions, and frequency of HbA1c measurement.

RESULTS: Over a mean follow-up of 6.3 years, 155 individuals (4.5%) were diagnosed with dementia. Patients with ≥50% of HbA1c measurements at 8-8.9% (64-74 mmol/mol) and ≥9% (≥75 mmol/mol) had 65% and 79% higher risk of dementia, respectively, compared with those with <50% of measurements exposed (HbA1c 8-8.9% adjusted hazard ratio [aHR] 1.65 [95% CI 1.06, 2.57] and HbA1c ≥9% aHR 1.79 [95% CI 1.11, 2.90]). By contrast, patients with ≥50% of HbA1c measurements at 6-6.9% (42-52 mmol/mol) and 7-7.9% (53-63 mmol/mol) had a 45% lower risk of dementia (HbA1c 6-6.9% aHR 0.55 [95% CI 0.34, 0.88] and HbA1c 7-7.9% aHR 0.55 [95% CI 0.37, 0.82]).

CONCLUSIONS: Among older patients with type 1 diabetes, those with majority exposure to HbA1c 8-8.9% and ≥9% had increased dementia risk, while those with majority exposure to HbA1c 6-6.9% and 7-7.9% had reduced risk. Currently recommended glycemic targets for older patients with type 1 diabetes are consistent with healthy brain aging.

Original languageEnglish (US)
Pages (from-to)2339-2345
Number of pages7
JournalDiabetes Care
Volume41
Issue number11
DOIs
StatePublished - Nov 1 2018

Fingerprint

Type 1 Diabetes Mellitus
Dementia
Hemoglobins
Health
Brain
Life Expectancy
Proportional Hazards Models
Comorbidity
Delivery of Health Care

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Lacy, M. E., Gilsanz, P., Karter, A. J., Quesenberry, C. P., Pletcher, M. J., & Whitmer, R. (2018). Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care, 41(11), 2339-2345. https://doi.org/10.2337/dc18-0073

Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. / Lacy, Mary E.; Gilsanz, Paola; Karter, Andrew J.; Quesenberry, Charles P.; Pletcher, Mark J.; Whitmer, Rachel.

In: Diabetes Care, Vol. 41, No. 11, 01.11.2018, p. 2339-2345.

Research output: Contribution to journalArticle

Lacy, ME, Gilsanz, P, Karter, AJ, Quesenberry, CP, Pletcher, MJ & Whitmer, R 2018, 'Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes', Diabetes Care, vol. 41, no. 11, pp. 2339-2345. https://doi.org/10.2337/dc18-0073
Lacy ME, Gilsanz P, Karter AJ, Quesenberry CP, Pletcher MJ, Whitmer R. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care. 2018 Nov 1;41(11):2339-2345. https://doi.org/10.2337/dc18-0073
Lacy, Mary E. ; Gilsanz, Paola ; Karter, Andrew J. ; Quesenberry, Charles P. ; Pletcher, Mark J. ; Whitmer, Rachel. / Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. In: Diabetes Care. 2018 ; Vol. 41, No. 11. pp. 2339-2345.
@article{b18a197aa56d442799109be5865e3606,
title = "Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes",
abstract = "OBJECTIVE: Individuals with type 1 diabetes have experienced an increase in life expectancy, yet it is unknown what level of glycemic control is ideal for maintaining late-life brain health. We investigated the association of long-term glycemic control with dementia in older individuals with type 1 diabetes.RESEARCH DESIGN AND METHODS: We followed 3,433 members of a health care system with type 1 diabetes, aged ≥50 years, from 1996 to 2015. Repeated measurements of hemoglobin A1c (HbA1c), dementia diagnoses, and comorbidities were ascertained from health records. Cox proportional hazards models were fit to evaluate the association of time-varying glycemic exposure with dementia, with adjustment for age, sex, race/ethnicity, baseline health conditions, and frequency of HbA1c measurement.RESULTS: Over a mean follow-up of 6.3 years, 155 individuals (4.5{\%}) were diagnosed with dementia. Patients with ≥50{\%} of HbA1c measurements at 8-8.9{\%} (64-74 mmol/mol) and ≥9{\%} (≥75 mmol/mol) had 65{\%} and 79{\%} higher risk of dementia, respectively, compared with those with <50{\%} of measurements exposed (HbA1c 8-8.9{\%} adjusted hazard ratio [aHR] 1.65 [95{\%} CI 1.06, 2.57] and HbA1c ≥9{\%} aHR 1.79 [95{\%} CI 1.11, 2.90]). By contrast, patients with ≥50{\%} of HbA1c measurements at 6-6.9{\%} (42-52 mmol/mol) and 7-7.9{\%} (53-63 mmol/mol) had a 45{\%} lower risk of dementia (HbA1c 6-6.9{\%} aHR 0.55 [95{\%} CI 0.34, 0.88] and HbA1c 7-7.9{\%} aHR 0.55 [95{\%} CI 0.37, 0.82]).CONCLUSIONS: Among older patients with type 1 diabetes, those with majority exposure to HbA1c 8-8.9{\%} and ≥9{\%} had increased dementia risk, while those with majority exposure to HbA1c 6-6.9{\%} and 7-7.9{\%} had reduced risk. Currently recommended glycemic targets for older patients with type 1 diabetes are consistent with healthy brain aging.",
author = "Lacy, {Mary E.} and Paola Gilsanz and Karter, {Andrew J.} and Quesenberry, {Charles P.} and Pletcher, {Mark J.} and Rachel Whitmer",
year = "2018",
month = "11",
day = "1",
doi = "10.2337/dc18-0073",
language = "English (US)",
volume = "41",
pages = "2339--2345",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "11",

}

TY - JOUR

T1 - Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes

AU - Lacy, Mary E.

AU - Gilsanz, Paola

AU - Karter, Andrew J.

AU - Quesenberry, Charles P.

AU - Pletcher, Mark J.

AU - Whitmer, Rachel

PY - 2018/11/1

Y1 - 2018/11/1

N2 - OBJECTIVE: Individuals with type 1 diabetes have experienced an increase in life expectancy, yet it is unknown what level of glycemic control is ideal for maintaining late-life brain health. We investigated the association of long-term glycemic control with dementia in older individuals with type 1 diabetes.RESEARCH DESIGN AND METHODS: We followed 3,433 members of a health care system with type 1 diabetes, aged ≥50 years, from 1996 to 2015. Repeated measurements of hemoglobin A1c (HbA1c), dementia diagnoses, and comorbidities were ascertained from health records. Cox proportional hazards models were fit to evaluate the association of time-varying glycemic exposure with dementia, with adjustment for age, sex, race/ethnicity, baseline health conditions, and frequency of HbA1c measurement.RESULTS: Over a mean follow-up of 6.3 years, 155 individuals (4.5%) were diagnosed with dementia. Patients with ≥50% of HbA1c measurements at 8-8.9% (64-74 mmol/mol) and ≥9% (≥75 mmol/mol) had 65% and 79% higher risk of dementia, respectively, compared with those with <50% of measurements exposed (HbA1c 8-8.9% adjusted hazard ratio [aHR] 1.65 [95% CI 1.06, 2.57] and HbA1c ≥9% aHR 1.79 [95% CI 1.11, 2.90]). By contrast, patients with ≥50% of HbA1c measurements at 6-6.9% (42-52 mmol/mol) and 7-7.9% (53-63 mmol/mol) had a 45% lower risk of dementia (HbA1c 6-6.9% aHR 0.55 [95% CI 0.34, 0.88] and HbA1c 7-7.9% aHR 0.55 [95% CI 0.37, 0.82]).CONCLUSIONS: Among older patients with type 1 diabetes, those with majority exposure to HbA1c 8-8.9% and ≥9% had increased dementia risk, while those with majority exposure to HbA1c 6-6.9% and 7-7.9% had reduced risk. Currently recommended glycemic targets for older patients with type 1 diabetes are consistent with healthy brain aging.

AB - OBJECTIVE: Individuals with type 1 diabetes have experienced an increase in life expectancy, yet it is unknown what level of glycemic control is ideal for maintaining late-life brain health. We investigated the association of long-term glycemic control with dementia in older individuals with type 1 diabetes.RESEARCH DESIGN AND METHODS: We followed 3,433 members of a health care system with type 1 diabetes, aged ≥50 years, from 1996 to 2015. Repeated measurements of hemoglobin A1c (HbA1c), dementia diagnoses, and comorbidities were ascertained from health records. Cox proportional hazards models were fit to evaluate the association of time-varying glycemic exposure with dementia, with adjustment for age, sex, race/ethnicity, baseline health conditions, and frequency of HbA1c measurement.RESULTS: Over a mean follow-up of 6.3 years, 155 individuals (4.5%) were diagnosed with dementia. Patients with ≥50% of HbA1c measurements at 8-8.9% (64-74 mmol/mol) and ≥9% (≥75 mmol/mol) had 65% and 79% higher risk of dementia, respectively, compared with those with <50% of measurements exposed (HbA1c 8-8.9% adjusted hazard ratio [aHR] 1.65 [95% CI 1.06, 2.57] and HbA1c ≥9% aHR 1.79 [95% CI 1.11, 2.90]). By contrast, patients with ≥50% of HbA1c measurements at 6-6.9% (42-52 mmol/mol) and 7-7.9% (53-63 mmol/mol) had a 45% lower risk of dementia (HbA1c 6-6.9% aHR 0.55 [95% CI 0.34, 0.88] and HbA1c 7-7.9% aHR 0.55 [95% CI 0.37, 0.82]).CONCLUSIONS: Among older patients with type 1 diabetes, those with majority exposure to HbA1c 8-8.9% and ≥9% had increased dementia risk, while those with majority exposure to HbA1c 6-6.9% and 7-7.9% had reduced risk. Currently recommended glycemic targets for older patients with type 1 diabetes are consistent with healthy brain aging.

UR - http://www.scopus.com/inward/record.url?scp=85055174118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055174118&partnerID=8YFLogxK

U2 - 10.2337/dc18-0073

DO - 10.2337/dc18-0073

M3 - Article

C2 - 30181165

AN - SCOPUS:85055174118

VL - 41

SP - 2339

EP - 2345

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 11

ER -